What should I do if I become drug-resistant?

Bituvi (Bicronol Tablets) is a compound single-tablet preparation used to treat human immunodeficiency virus 1 (HIV-1) infection. The emergence of drug resistance may be caused by a variety of factors, including irregular medication, drug metabolism, insufficient drug concentration, immune system status, and viral mutation.

Once it is discovered that there may be resistance to Bituvi, patients should consult a professional doctor immediately. Doctors will evaluate the degree of drug resistance based on the patient's specific conditions, including viral load, CD4 cell count, drug resistance test results, etc., and formulate corresponding response strategies.

Doctors may recommend that patients switch to other antiretroviral drugs to replace Bituvir for which resistance has developed. When choosing a new drug, doctors consider factors such as drug interactions, the patient's medical condition, and the drug's availability. To more effectively control viral replication, doctors may recommend a combination of multiple antiretroviral drugs to form a new treatment regimen. This combination therapy can improve treatment efficacy and reduce the development of drug resistance.

During the treatment process, patients should regularly detect indicators such as viral load and CD4 cell count to evaluate the treatment effect and detect drug resistance in a timely manner. Doctors will conduct close follow-up management of patients, including asking about the condition, adjusting drug dosage, dealing with drug side effects, etc., to ensure the smooth implementation of the treatment plan.

Poor lifestyle habits may affect drug metabolism and absorption, thereby increasing the risk of drug resistance. Therefore, patients should quit smoking, limit alcohol consumption, and improve their lifestyle. Proper exercise can promote blood circulation and endocrine balance, improve immunity, and help resist the replication and spread of viruses.